Search
for
Sort by
Research 331–360 of 1000+
- Green Tea as a Supportive Therapy for PCOS: Evaluating Its Impact on Symptom Relief
- Management of Polycystic Ovarian Syndrome: Looking Beyond the Ovaries
- Hirsutism, Acne, and Hair Loss: Management of Hyperandrogenic Cutaneous Manifestations of Polycystic Ovary Syndrome
- Hirsutism
- Update on nail disorders
- Metabolic syndrome
- Inositol and FSH: A new frontier for the androgenetic alopecia treatment
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- Role of Metformin in Acanthosis Nigricans
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- A comparative study on insulin resistance in females of reproductive age group with acne vulgaris
- Association between Insulin Resistance and Hyperandrogenism among Women with PCOS in Pakistan
- Exploring the Causal Relationship and Molecular Mechanisms Between Fasting Insulin and Androgenetic Alopecia: A Mendelian Randomization Study with Bioinformatics Analysis
- A hair-follicle reconstructed in vitro immunocompetent skin model for prediction of the sensitizing potential of chemicals
- Metabolic effects of duodenal mucosal resurfacing on insulin resistant women with polycystic ovary syndrome
- Assessment of adipokines, hormonal profile, lipid profile, and insulin resistance in patients with androgenetic alopecia
- NEW PROPRIETARY BRANDS: Gabapentin
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- NEW PROPRIETARY BRANDS: Cefaclor monohydrate
- NEW FORMULATIONS: Glatiramer acetate
- Obesity and polycystic ovary syndrome
- Hormonal contraceptives: pharmacology tailored to women's health
- Mood and Sexual Function in Polycystic Ovary Syndrome
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome